Poland Cancer Research
Central European Oncology Hub with Growing Clinical Trial Infrastructure
EU Clinical Trial Standards
Regional research hub
Precision Oncology Programs
Molecular profiling expansion
Central European Leader
International collaboration
Central European Precision Oncology Network
Poland established a regional precision oncology network connecting research centers across Central and Eastern Europe for collaborative clinical trials.
Impact:
Enabling precision medicine access across Central Europe
Advanced Lung Cancer Research Programs
Polish researchers are advancing targeted therapies for non-small cell lung cancer with focus on molecular profiling and personalized treatment strategies.
Impact:
Improving outcomes for lung cancer patients regionally
Expanding International Clinical Trial Infrastructure
Poland has become a key site for multinational oncology trials, offering EU-standard clinical research with growing infrastructure.
Impact:
Bringing global innovations to Central European patients
Molecular Diagnostics Development
Poland is developing affordable molecular diagnostic platforms for cancer detection and treatment selection in emerging European markets.
Impact:
Making precision diagnostics accessible across the region
Hematologic Malignancies Research
Polish centers are advancing research in leukemia and lymphoma treatments, with strong participation in European cooperative groups.
Impact:
Improving blood cancer treatment outcomes in Central Europe
Maria Skłododowska-Curie National Research Institute of Oncology
Warsaw
Poland's leading cancer research institute. Comprehensive oncology research, clinical trials, and regional collaboration hub.
Key Specialties:
Medical University of Gdańsk Cancer Center
Gdańsk
Advanced oncology research with focus on lung and GI cancers. Active participant in international trial networks.
Key Specialties:
Institute of Hematology and Transfusion Medicine
Warsaw
Leading center for blood cancer research in Poland. European cooperative group member for leukemia and lymphoma studies.
Key Specialties:
Poland participates in major European and international oncology trials
Targeted Therapy for Non-Small Cell Lung Cancer
Multi-center trial testing novel targeted therapies for EGFR-mutant lung cancer in Central European populations.
Acute Lymphoblastic Leukemia Treatment Protocol
European collaborative study evaluating new treatment combinations for adult acute lymphoblastic leukemia.
Precision Oncology Registry Study
Regional registry collecting molecular profiling data to guide treatment decisions across Central European cancer centers.
Registry-listed trials for Poland currently tracked in our database, sourced from public trial registries.
